chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up with a headache and fatigue, as well as soreness near area of injection. Energy was very low and felt very tired. Tried to sleep at around 12:00 PM but had a thumping in my head that would not let me fall asleep. Around 3:00 PM tried to sleep again but being shivering/shaking a lot despite being under a blanket and comforter. Eventually needed to take a hot bath for around 45 minutes to an hour. Took my temperature while in the bath which read 96°F (although that thermometer may not be the most accurate.) After the bath I went directly to bed with a comforter, blanket and weighted blanket and was able to fall asleep for about 90 minutes. Was no longer shivering when I awoke and felt much better. Went to sleep at around 9:00 PM and felt fine when I woke up the next morning.
From telephone contact with pt, it was stated that she received a DT pediatric vaccination in her left deltoid, date not specified. That same day, she experienced a seizure. She was evaluated in ER and discharged. Pt was admitted the following day, to ER, with seizures, treated with Valium and admitted to the hospital. Pt experienced 7 seizures in 4 days. The pt also experienced headache, temperature of 101F, local reaction of redness and swelling at the injection site, weakness and fatigue. Pt had her last tetanus shot 7-8 years ago. This vaccination was a booster; the pt was instructed to have per nursing school.
Rash on both wrist area. Pimples on each armpit/breast area and left forearm.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 06-JUN-2011, the patient was inoculated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. On or about 18-JUL-2016, the patient was treated at a Dermatology Office for the onset of a vesicular rash, which was diagnosed as shingles. The patient has been prescribed valacyclovir for management of her painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
back muscle ache; inflammation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 10:30 (Lot number: ER8730, Expiration Date: 03Apr2021) at the age of 71 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 01, Date: 04Mar2021, Time: 10:30 am, Anatomical site of injection: Left arm, Batch/Lot Number: EN6205), administration date: 04Mar2021, when the patient was 71 years old, for Covid-19 immunization. The following information was reported: MYALGIA (non-serious) with onset 26Mar2021, outcome "not recovered", described as "back muscle ache"; INFLAMMATION (non-serious) with onset 2021, outcome "not recovered", described as "inflammation". The events "back muscle ache" and "inflammation" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of myalgia, inflammation.  Additional information: I have had back muscle ache ever since second Vaccination on 25Mar2021. The muscle ache began the next morning 26Mar2021. I have gone to an orthopedic specialist and they x-rayed my back and said backbone is fine with no problems. They say it must be inflammation so they prescribed Meloxicam for 30 days. I have been on them 21 days and back muscles still ache. So what I am asking is were there any reported problems on back muscle ache during the testing period? If so can someone tell me the fix before the orthopedic medical field wastes their time and my time researching what to do. Any assistance on the fix would be much appreciated.   Follow-up attempts are completed. No further information is expected.
Right upper thigh erythema 8 X 10 cm induration 3.5 X 5 cm erythema centrally covering. Warm to touch. Started 3/22/06. Vaccines given 3/21/06 Tx'd with benadryl 1.5-2 tsp tid. Keflex 250/s 1 tsp tid #150 cc.
24 hours after vaccine, slight erythema. At 144 hours, 2" induration with erythema, pain.
This spontaneous report as received from a physician refers to a female patient of 56 or 57 year old. The patient's medical history included type II diabetes. There were no drug reaction/allergies. About 5 to 6 months ago (approximately in April 2014), the patient was vaccinated with a dose of ZOSTAVAX vial, subcutaneous (dose, lot # and expired date were not reported). There was concomitant medication, but unspecified by the reporter. On an unspecified date in 2014, the patient experienced a little pain and swelling around the injection site of the ZOSTAVAX. No treatment was given for adverse events. No lab diagnosis studies were performed. On an unspecified date in 2014, The patient was recovered from adverse events. The relationship between adverse events and ZOSTAVAX was not reported. Additional information has been requested.
I experienced severe itching on my torso and was covered with a red rash from my chest all the way up to my neck, face, and down my arms. It was so bad that I ended up going to Emergency Care. The Nurse Practitioner stated that it was definitely related to the vaccine. During the night it begin to spread to other places on my body and the next morning I went to PCP and they asked if it was a reaction to something I washed my clothes in or a perfume that I recently purchased and finally gave me a steroid injection which helped my symptoms and within a few days the rashes were gone. I was told that it wasn't a reaction to the vaccine because it was 48-hours later; however, I did not have any reaction to the detergent or perfume (still wear the same one with any issues).
Patient with redness and large area of swelling on the upper arm at the site of the immunization.
It was reported by a health care professional concerning an approximately 70 year old female who resides in a nursing home, and was administered Fluzone SV 2002-2003 USF (Lot number not reported). The patient was inadvertently administered 5 cc  of the vaccine instead of 0.5 cc in the deltoid approximately 10 days ago. Approximately 4-6 hours after administration, the patient experienced vomiting and other unspecified symptoms. A family member brought the patient to the physician's office. She then went to the emergency room and was admitted to the hospital and at some point was placed on a ventilator. Additionally, there were several episodes over an eight day period while on the ventilator where the patient's heart stopped beating. A temporary pacemaker was used for a few days before a permanent pacemaker was inserted. The patient's lips were swollen during the hospital stay. This information was provided to the  reporter by the patient's great niece. As per the reporter, the niece did not know what the impression of the treating physician was at the hospital. The patient's son can provide time more information if unable to obtain from the nursing home. It was not reported whether the patient recovered.
Swelling of upper arm from shoulder to elbow, red, swollen, burning sensation, lasted two days. Lymph node in neck tender. Treated with ice packs and TYLENOL but was very painful.
The initial vaccine had localized pain. By the next day, I was extremely tiered and woke up with generalized body aches and pains, mostly in my knees and joints. When I stood up, I felt lightheaded. I took Tylenol and slept for all afternoon, then went to be very early. I felt better the next day. However, I continue to feel lightheaded in the morning on first awakening and when I lie down to get up. It is slowly less noticeable, but it has not completely resolved.
adm to PICU @ hosp 27AUG97 p/exp fever & acrocyanosis;pt was followed clinically in the hosp for 72hr & was discharged on 30AUG97;pt had a cardiology follow up for prev dx ASD;
"appears to present idiopathic thrombocytopenic purpura that may have been associated with her reception of several immunizations provided at the latter part of July...A treatment was provided with WinRho two weeks prior to this admission and appeared to show an initial increase in the platelet count,...but at subsequent evaluation, platelet count has fallen once again."  - 1/13/06 Review 7-page med. Rec. confirms admission on 8/19/05 with diagnosis of severe thrombocytopenia.The 5-page record confirms readmission on 9/1/05 for persistent thrombocytopenia. Platelet count had fallen back to 8 and the plan was to treat with IVIG as a single infusion.
Experienced headache and felt like she was going to pass out within minutes of receiving vaccine, placed head between knees, smelling salts, Moved to stretcher.  BP 190/90; pulse 90s; pulse ox 98% Room air. Pt Awake, Alert and, Oriented x 3.  "numb sensation; almost like my nose feels broken from nose to forehead." Symptoms reduces, still with 'funny taste' and agreed to ED. EKG OK, believe vasovagal episode. Discharged to home when symptom free.
Adverse effect from the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Adverse effect from the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse effect from the vaccine). At the time of the report, VACCINATION COMPLICATION (Adverse effect from the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment medications was not reported.
3 hours after shot, sick to my stomach. Later in day arm red-swollen severe pain arm-hand-fingers and armpit-shoulder-neck. Severe fatigue, dizzy, etc. lasted 2 1/2 days.
Case number PHEH2013US016728 is a spontaneous report received from the nurse on 06 Aug 2013. This report refers to an adult female patient. The patient had a history of allergies to BACTRIM and DURACEF. She was vaccinated with the first dose of RABAVERT (batch number: 473011C) intramuscularly at a dose of 1 ml, in the left deltoid on 07 Sep 2011. The patient received second and third doses of RABAVERT (batch number: 473011C) each 1ml intramuscularly in the right deltoid on 14 Sep 2011 and 05 Oct 2011 respectively. On 11 Jun 2013, her rabies titer equivocal levels were insufficient and it was reported that she needs a rabies booster. The event outcome was not reported. The case was assessed as medically significant by the reporter. The causality was not reported.
Have developed large red welt at injection that has been spreading slowly and continuously over past 30 hours.  Started approximately size of dime, is larger than a quarter after 30 hours.  Red in color, hot, swollen.  Left ear is starting to get swollen and painful on inside - due to swollen lymph node under ear.
Patients received expired doses; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received expired doses) in a 70-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 31-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received expired doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received expired doses) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications were provided by the Reporter No Treatment Medications were provided by the Reporter   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 25-Apr-2022: Follow-up received and patient demographics updated, vaccine information and event start date added.
Patient received flu shot at 3:30 pm. Felt nauseous on the ride home. Vomited at 8:00pm. Felt better right after.
Patient experienced redness at the injection site after her first vaccine done; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE ERYTHEMA (Patient experienced redness at the injection site after her first vaccine done) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No relevant medical history was reported. No relevant concomitant medications reported.     In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE ERYTHEMA (Patient experienced redness at the injection site after her first vaccine done). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (Patient experienced redness at the injection site after her first vaccine done) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment medication include antihistamine and Tylenol.   This case was linked to MOD-2021-026810 (Patient Link).
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 73-year-old female patient who received SHINGRIX (batch number B334Y, expiry date 17th October 2020) for prophylaxis. On 20th May 2018, the patient received SHINGRIX .5 ml. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced pain in arm, mobility decreased and neck pain. On an unknown date, the outcome of the pain in arm, mobility decreased and neck pain were not recovered/not resolved. The reporter considered the pain in arm, mobility decreased and neck pain to be related to SHINGRIX. Additional details were provided as follows: At 13:05 hours, the patient received SHINGRIX on right arm. Sometimes later, the patient developed pain going up her arm and radiating into her neck, with some loss of movement in the arm. The patient was instructed to ice the area, and also used heat which did not help.
I continued to experience the left upper jaw pain I was having from the first vaccine. My symptoms developed into something, I had pain in my left upper jaw, and I thought it was tooth so I went to dentist. I even got a CT scan of my jaw and it was not my tooth. As the days went by, the pain radiated to the top of my head and shoulder. This pain I experienced came and went. I ended up calling my doctor and he gave me treatment for the pain. I have never experienced this kind of pain before, it was a neurological pain. My symptoms have resolved today and I have no pain today.
ADMINISTERED IN LEFT DELTOID ON 2/4/2009; WITH IN 3-4 HOURS EXPERIENCED SEVERE PAIN IN DELTOID MUSCLE, JOINT OF LEFT SHOULDER WITH PAIN RADIATING UP LEFT NECK TO LEFT SCALPULAR AND CHEST PAIN WITH SEVERE HEADACHE; UNABLE TO MOVE LEFT ARM WITHOUT EXCURIATING PAIN....CALLED MD OFFICE FOR FOLLOW UP APPT AND WAS UNABLE TO SCHEDULE DUE TO NO AVAILABLE APPTS ON 2/5/09
Developed swelling, redness at injection site. Warm to touch. Also complains of headache, diarrhea. Self treated with alcohol.
The day after the shot I began a flare-up of psoriasis, an ongoing condition. By evening it had escalated to the point that my eyes were swollen shut. I had a fierce itching and burning of my face. I asked my husband if he would take me to the emergency room. He then suggested that he remembered having prednisone tablets. Without them I know I would have gotten much worse. I couldn't get in to see my dermatologist until another day later. They gave me a 40ml steroid shot. It called everything down but took another week to subside. I've had a similar reaction to the Fluzone shot back in Sept, 2020.
I95.9 HYPOTENSION 4/13/2022 MOOD DISORDER, UNSPECIFIED TYPE
Patient developed a bruise at the injection site. I saw it after 1 week, and it was healing (turning yellow), and after 2 weeks, when it was still yellow but almost healed. After 1 week, patient starting developing rashes on different parts of his body (arms, legs, torso). They are itchy and red.
Vaccine administered 1 month too early for routine 2nd booster scheduling at 5:36 on 4/14/2022 due to confusion between first booster and second booster spacing. Pt monitored for 15 minutes after administration, provided with education on potential side effects and adverse effects. No obvious signs of distress noted. Pt didn?t report any adverse effects during or after monitoring.
Redness left side of neck. No itch, pain, discomfort. Rash became extended to mid portion of neck.  Took otc Benadryl. Pt was also given Pneumovax vaccine.
rebound Covid 8 days post Rx wit Paxlovid, Ag+; This spontaneous case was reported by a non-health professional and describes the occurrence of COVID-19 (rebound Covid 8 days post Rx wit Paxlovid, Ag+) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    Concurrent medical conditions included Lymphoma, Polymyalgia rheumatica and Penicillin allergy.   On 21-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Dec-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 15-May-2022, the patient experienced COVID-19 (rebound Covid 8 days post Rx wit Paxlovid, Ag+). At the time of the report, COVID-19 (rebound Covid 8 days post Rx wit Paxlovid, Ag+) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-May-2022, SARS-CoV-2 test: ag+ (Positive) Ag+.         The concomitant medication was not provided. The patient had rebound Covid 8 days post treatment with Paxlovid, Ag positive.  Company comment: This spontaneous case concerns  a patient of unspecified age and gender with no relevant medical history, who experienced the unexpected non-serious adverse events of special interest, COVID-19 (COVID-19) and unexpected, which occurred 1 month 7 days after receiving the fourth dose of mRNA-1273 vaccine. The event COVID-19 (rebound Covid 8 days post Rx wit Paxlovid, Ag+). SARS-CoV-2 test was positive as on 15-May-2022. Ongoing Covid 19 pandemia could be considered as confounder to the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.; Sender's Comments: This spontaneous case concerns a patient of unspecified age and gender with no relevant medical history, who experienced the unexpected non-serious adverse events of special interest, COVID-19 (COVID-19) and unexpected, which occurred 1 month 7 days after receiving the fourth dose of mRNA-1273 vaccine. The event COVID-19 (rebound Covid 8 days post Rx wit Paxlovid, Ag+). SARS-CoV-2 test was positive as on 15-May-2022. Ongoing Covid 19 pandemia could be considered as confounder to the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.
Pt experienced right knee pain, felt like a nail in the knee, left shoulder as if baseball on shoulder; right shin pain worse, right ankle pain, lower back pain, very cold all over, couldn't sit lower legs hurt, remaining right leg weakness
Additional info received on 10/17/02, provided quality assurance lab results. A pediatrician reported that a 15 month old male recieved his fourth dose of Prevnar on 9/6/02. He also received Haemophilus influenzae B (manuf unk) vaccine within four weeks of Prevnar. On 9/7/02, he experienceda seizure. This event is considered medically important (OMIC).
My decades-long MILD tinnitus has become EXTREME.  It started a few hours after vaccination, and has not stopped since (14 days).
Lacey rash on left leg.  Child was taken to local ER by mother for evaulation.  Was told it was "just a reaction to shots".
Seizure: unresponsive, lasting for approximately 5 minutes. Vomiting immediately following seizure and post-ictal state thereafter.
at 10:30 pm (08/10/2020) patient felt her finger tingling and at 3:00 am (08/11/2020) woke up with her both  hands swollen. Mom then gave her 1 tablet of Allegra, called clinic this morning to inform PCP and was told to come in for evaluation. PCP prescribe  hydrocortisone topical ointment, 2.5%, 1 app, applied topically, hydroxyzine tablet, hydrochloride 10 mg, prednisone tablet, 20 mg, 1 tab(s), orally, once a day.
Patient received 2nd dose less than 24 days from 1st dose, after only 23 days.